Association between systemic non-criteria aps manifestations and antibody type and level: Results from the Serbian National Cohort Study

Clinical and Experimental Rheumatology

Volumn 31, Issue 2, 2013, Pages 0234-0242

  Stojanovich, Ljudmila ^a   Kontic, Milica ^b   Djokovic, Aleksandra ^a   Marisavljevic, Dragomir ^a   Ilijevski, Nenad ^c   Stanisavljevic, Natasa ^a   Mikovic, Zeljko ^d   Petkovic, Milena ^a   Kovcin, Vladimir ^a  

^a University Medical Centre Bezanijska Kosa   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Institute of Cardiovascular Disease Dedinje   (Serbia)

^d University Clinic of Gynaecology and Obstetrics   (Serbia)

Author keywords

Antiphospholipid antibody type and level; Antiphospholipid syndrome; Hughes syndrome; Non criteria manifestations

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; BETA2 GLYCOPROTEIN 1; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CHOREA; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EPILEPSY; FEMALE; HUMAN; LABORATORY TEST; LIVEDO RETICULARIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PREVALENCE; PRIORITY JOURNAL; PSEUDOVASCULITIS; SERBIA; SKIN ULCER; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TRANSTHORACIC ECHOCARDIOGRAPHY; UNSTABLE ANGINA PECTORIS; VALVULAR HEART DISEASE; VASCULITIS; BLOOD; CHI SQUARE DISTRIBUTION; IMMUNOLOGY; MIDDLE AGED; PREDICTIVE VALUE; PROSPECTIVE STUDY;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVEDO RETICULARIS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; SERBIA; SKIN ULCER; THROMBOCYTOPENIA; VASCULITIS;

MLCS; MLOWN;

EID: 84875776552     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. UTHMAN I, KHAMASHTA MA: Ethnic and geographical variation in antiphospholipid (Hughes) syndrome. Ann Rheum Dis 2005; 64: 1671-6.
2. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
3. STOJANOVICH L: Pulmonary manifestations in antiphospholipid syndrome. Autoimmun Rev 2006; 5:344-8.
4. SUVAJAC G, STOJANOVICH L, MILENKOVICH S: Ocular manifestations of antiphospholipid syndrome. Autoimmun Rev 2007; 6: 409-14.
5. ROTTEM M, KRAUSE I, FRASER A, STOJANOVICH L, ROVENSKY J, SHOENFELD Y: Autoimmune haemolytic anaemia in the antiphospholipid syndrome. Lupus 2006; 15: 473-7.
6. BOMBARDIER C, GLADMAN DD, UROWITZ MB, CARON D, CHANG CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-40.
7. STOJANOVICH L, ZADMAN-GODDARD G, PAVLOVICH S, SIKANICH N: Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev 2007; 6: 421-6.
8. RUYZ-IRASTORZA G, CROWTHER M, BRANCH W, KHAMASHTA MA: Antiphospholipid syndrome. Lancet 2010; 376: 1498-509.
9. SHOENFELD Y, ZANDMAN-GODDARD G, STOJANOVICH L et al.: The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases Isr Med Assoc J 2008; 10: 8-12.
10. BERTOLACCINI ML, GOMEZ S, PAREJA JF et al.: Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis 2005; 64: 1639-43.
11. HARRIS EN, PIERANGELI SS: 'Equivocal' antiphospholipid syndrome. J Autoimmun 2000; 15: 81-5.
12. BIGGIOGGERO M, MERONI PL: The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev 2010; 9: A299- A304
13. VIANNA JL, KHAMASHTA MA, ORDI-ROS J et al.: Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 1994; 96: 3-9.
14. PENGO V, BIASIOLO A, PEGORARO C, CUCCHINI U, NOVENTA F, ILICETO S: Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost 2005; 93: 1147-52.
15. KRAUSE I, LEV S, FRASER A et al.: Close association between valvular heart disease and central nervous system manifestations in the antiphospholipid syndrome. Ann Rheum Dis 2005; 64: 1490-3.
16. REES JD, LANCA S, MARQUES PV et al.: Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann Rheum Dis 2006; 65: 109-11.
17. FRANCÉS C, PIETTE JC: The mystery of Sneddon's syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus. J Autoimmun 2000; 15: 139-43.
18. CUADRADO MJ, MUJIC F, MUNOZ E, KHAMASHTA MA, HUGHES GR: Thrombocytopenia in the antiphospholipid syndrome. Ann Rheum Dis 1997; 56: 194-6.
19. CERVERA R, CONTI F, DORIA A, LACCARINO L, VALESINI G: Does seronegative antiphospholipid syndrome really exist? Autoimmune Rev 2012; 11: 581-4.
20. MIYAKIS S, LOCKSHIN MD, ATSUMI T et al.: International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
21. WHISNANT JP: Special report from the National Institute of Neurologic Disorder and Stroke. Classification of cerebrovascular diseases III. Stroke 1990; 21: 637-76.
22. ZOGHBI WA, ENRIQUEZ-SARANO M, FOSTER E et al.: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
23. ASHERSON RA, CERVERA R: Unusual manifestations of the antiphospholipid syndrome. Clin Rev Allergy Immunol 2003; 25: 61-78.
24. ASHERSON RA, CERVERA R, KLUMB E et al.: Amputation of Digits or Limbs in Patients with Antiphospholipid Syndrome. Semin Arthritis Rheum 2008; 38: 124-31.
25. HUGHES GR: The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-4.
26. BERTOLACCINI ML, KHAMASHTA MA, HUGHES GR: Diagnosis of antiphospholipid syndrome. Nat Clin Pract Rheumatol 2005; 1: 40-6.
27. MARAI I, LEVI Y, GODARD G, SHOENFELD Y: Following 90 patients with antiphospholipid syndrome with antibody levels and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population. Harefuah 2001; 140: 495-500, 565.
28. LIU G, WANG Z, CHAO V et al.: The correlation between anti-cardiolipin antibodies and disease activity in patients with systemic lupus erythematosus. Hua Xi Yi Ke Da Xue Xue Bao 2000; 31: 223-5.
29. SANNA G, BERTOLACCINI ML, CUADRADO MJ, KHAMASHTA MA, HUGHES GR: Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology (Oxford) 2003; 42: 200-13.
30. STOJANOVICH L, MILOVANOVICH B, DE LUKA SR et al.: Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjögren syndrome and other autoimmune diseases. Lupus 2007; 16: 181-5.
31. FIALLO P, TOMASINA C, CLAPASSON A, CARDO PP: Antibodies to beta(2)-glycoprotein I in ischemic stroke. Cerebrovasc Dis 2000; 10: 293-7.
32. BRANDT JT, TRIPLETT DA, ALVING B, SCHARRER I: Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/ Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185-90.
33. ORTEGA-HERNANDEZ OD, AGMON-LEVIN N, BLANK M et al.: The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: Compelling evidence. J Autoimmun 2009; 32: 1-6.
34. ORZECHOWSKI NM, WOLANSKYJ AP, AHLSKOG JE, KUMAR N, MODER KG: Antiphospholipid antibody-associated chorea. J Rheumatol 2008; 35: 2165-70.
35. CIUBOTARU CR, ESFAHANI F, BENEDICT RH, WILD LM, BAER AN: Chorea and rapidly progressive subcortical dementia in antiphospholipid syndrome. J Clin Rheumatol 2002; 8: 332-9.
36. ZANDMAN-GODDARD G, CHAPMAN J, SHOENFELD Y: Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum 2007; 36: 297-315.
37. BREY RL: Differential diagnosis of central nervous system manifestations of the antiphospholipid antibody syndrome. J Autoimmun 2000; 15: 133-8.
38. STALC M, TOMSIC M, JEZOVNIK MK, POREDOS P: Endothelium-dependent and independent dilation capability of peripheral arteries in patients with systemic lupus erythematosus and antiphospholipid syndrome. Clin Exp Rheumatol 2011; 29: 616-23.
39. ASLANIDIS S, PYRPASOPOULOU A, DOUMAS M, TRIANTAFYLLOU A, CHATZIMICHAILIDOU S, ZAMBOULIS C: Association of capillaroscopic microhaemorrhages with clinical and immunological antiphospholipid syndrome. Clin Exp Rheumatol 2011; 29: 307-9.
40. RUIZ-IRASTORZA G, RAMOS-CASALS M, BRITO-ZERON P, KHAMASHTA MA: Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010; 69: 20-8.
41. ERKAN D, BARBHAIYA M, GEORGE D, SAMMARITANO L, LOCKSHIN M: Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-levels anti-β2-glycoprotein- I antibody positivity offer additional predictive information? Lupus 2010; 19: 613-9.
42. TOUBI E, I. KRAUSE, FRASER A et al.: Livedo reticularis is a marker for predicting multisystem thrombosis in antiphospholipid syndrome. Clin Exp Rheumatol 2005; 23: 499-504.
43. ERKAN D, PATEL S, NUZZO M et al.: Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology 2008; 47 (Suppl. 3): iii 23-7.
44. ERKAN D, LOCKSHIN MD: Non-criteria manifestations of antiphospholipid syndrome. Lupus 2010; 19: 424-7.
45. FRANCÉS C, PAPO T, WECHSLER B, LAPORTE JL, BIOUSSE V, PIETTE JC: Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients. Medicine (Baltimore) 1999; 78: 209-19.
46. ASHERSON RA, FRANSSCÉS C, IACCARINO L et al.: The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. Clin Exp Rheumatol 2006; 24 (Suppl. 40): S46-51.
47. PAIRA S, ROVERANO S, ZUNINO A, OLIVA ME, BERTOLACCINI ML: Extensive cutaneous necrosis associated with anticardiolipin antibodies. J Rheumatol 1999; 26: 1197-200.
48. LANGUREN M, BECERRIL B, CABRAL AR et al.: Characterization of monoclonal anti-β2- glycoprotein-I and anti-prothrombin antibody fragments generated by phage display from a patient with primary antiphospholipid syndrome. J Autoimmun 2006; 26: 57-65.
49. MERONI PI: Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity. J Autoimmun 2008; 30: 99-103.
50. KRAUSE I, BLANK M, FRASER A et al.: The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome. Immunobiology 2005; 210: 749-54.
51. GODEAU B, PIETTE JC, FROMONT P, INTRATOR L, SCHAEFFER A, BIERLING P: Specific antiplatelet glycoprotein autoantibodies are associated with thrombocytopenia of primary antiphospholipid syndrome. Br J Haematol 1997; 98: 873-9.
52. CERVERA R, ASHERSON RA, ACEVEDO ML et al.: Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 2004; 63: 1312-7.
53. SOLTESZ P, DER H, VERES K et al.: Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction. Rheumatology (Oxford) 2008; 47: 1628-34.
54. KHATTRI S, ZANDMAN-GODDARD G, PEEVA E: B-cell directed therapies in antiphospholipid- antibody syndrome - new directions based on murine and human data. Autoimmun Rev 2012; 11: 717-22.